Citius Oncology, Inc. CTOR Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s common stock shares issued?
- Citius Oncology, Inc. (CTOR) reported common stock shares issued of 93M in Q1 2026.
- How has Citius Oncology, Inc.'s common stock shares issued changed year-over-year?
- Citius Oncology, Inc.'s common stock shares issued increased by 29.9% year-over-year, from 71.6M to 93M.
- What is the long-term trend for Citius Oncology, Inc.'s common stock shares issued?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s common stock shares issued has grown at a 264.5% compound annual growth rate (CAGR), from 1.7M to 83.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.